Largest biotech by net assets

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Gilead Sciences leads the 24 biotech ranked by net assets, at SGD 29.3B, ahead of BioNTech (SGD 27.5B) and Biogen (SGD 23.5B). Figures as of 18 Nov 2026, 15:14 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
Gilead SciencesSGD 29.3B
Median
SGD 2.6B
Combined market value
SGD 1.09T
Countries
5

Market values as of .

Largest biotech by net assets
#CompanyNet assets ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Gilead SciencesGILD · Health CareSGD 29.3BSGD 270.6BSGD 218.13 0.65% down 33% up United States
2BioNTechBNTX · Health CareSGD 27.5BSGD 27.2BSGD 109.58 0.14% up 16% down Germany
3BiogenBIIB · Health CareSGD 23.5BSGD 47.7BSGD 322.75 0.20% down 49% up United States
4AmgenAMGN · Health CareSGD 11.2BSGD 314.2BSGD 580.83 1.64% down 34% up United States
5ModernaMRNA · Health CareSGD 11.2BSGD 107.7BSGD 266.06 0.23% down 755% up United States
6argenxARGX · Health CareSGD 9.4BSGD 77.9BSGD 1,239.30 1.43% up 4% up Belgium
7QiagenQGEN · Health CareSGD 4.9BSGD 13.2BSGD 64.04 0.18% down 12% up Netherlands
8Neurocrine BiosciencesNBIX · Health CareSGD 4.2BSGD 21.3BSGD 210.59 1.57% down 20% up United States
9VaxcytePCVX · Health CareSGD 3.5BSGD 12.1BSGD 76.21 0.51% down 22% up United States
10ExelixisEXEL · Health CareSGD 2.8BSGD 21.8BSGD 89.18 0.96% up 63% up United States
11Bio-TechneTECH · Health CareSGD 2.7BSGD 14.7BSGD 93.75 0.10% up 26% up United States
12RepligenRGEN · Health CareSGD 2.7BSGD 14.2BSGD 222.28 6.29% up 5% up United States
13CRISPR TherapeuticsCRSP · Health CareSGD 2.5BSGD 5.2BSGD 53.81 3.94% up 21% down Switzerland
14Revolution MedicinesRVMD · Health CareSGD 2.1BSGD 45.1BSGD 208.66 0.54% down 131% up United States
15Kymera TherapeuticsKYMR · Health CareSGD 2BSGD 13.6BSGD 158.83 1.36% up 87% up United States
16Krystal BiotechKRYS · Health CareSGD 1.6BSGD 11.8BSGD 398.97 3.63% up 46% up United States
17ImmunovantIMVT · Health CareSGD 1.1BSGD 9BSGD 43.73 2.11% up 43% up United States
18CG OncologyCGON · Health CareSGD 970.5MSGD 9.1BSGD 102.26 0.46% up 85% up United States
19Twist BioscienceTWST · Health CareSGD 609.9MSGD 10.3BSGD 151.34 4.79% up 340% up United States
20Scholar Rock HoldingSRRK · Health CareSGD 316.6MSGD 7.6BSGD 62.48 7.48% up 14% up United States
21Adaptive BiotechnologiesADPT · Health CareSGD 282.1MSGD 6BSGD 37.18 1.21% up 88% up United States
22Kodiak SciencesKOD · Health CareSGD 202.9MSGD 8.4BSGD 127.93 2.48% up 396% up United States
23Halozyme TherapeuticsHALO · Health CareSGD 62.9MSGD 14.3BSGD 125.31 1.26% up 37% up United States
24ImmunityBioIBRX · Health Care-SGD 645.4MSGD 9.1BSGD 8.56 6.07% up 193% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2895 SGD).

Questions and answers

Which biotech rank first by net assets?

Gilead Sciences (SGD 29.3B), BioNTech (SGD 27.5B) and Biogen (SGD 23.5B) are the top three of the 24 biotech ranked by net assets as of 18 Nov 2026, 15:14 UTC.

How many biotech are in this ranking?

24 are ranked by net assets.

What are these biotech worth together?

The 24 biotech ranked by net assets have a combined market value of SGD 1.09T as of 18 Nov 2026, 15:14 UTC.

What does ranking by net assets measure?

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Cite this page

Funkfolio, “Largest biotech by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=net-assets

Underlying data: Yahoo Finance; SEC EDGAR.